drugset / Trial / NCT01852513
Allergic Rhinitis Changes the Sinus Microbiome
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The investigators hypothesize that treatment with QNASL will reduce nasal mucosal inflammation induced by the allergy season and prevent the changes in the microbiome caused by the allergy season.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-11
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | beclomethasone dipropionate | Other / unclassified | 320 ug | Intranasal |